Department of Pediatrics, University of Arizona Health Sciences Center, Tucson, AZ 85724-5073, USA.
J Appl Genet. 2011 May;52(2):213-8. doi: 10.1007/s13353-010-0021-1. Epub 2010 Dec 18.
Although Niemann-Pick C1 disease has frequently been called "juvenile Alzheimer's", the effects of introducing Npc1 mutations into a mouse model of Alzheimer's have not previously been performed. We have crossed Npc1 (+/-) mice with APP/PS1 "Alzheimer's" mice and studied Aβ42 accumulation and amyloid plaque formation. Mice heterozygous for Npc1 and positive for the APP and PS1 transgenes accumulated Aβ42 more rapidly than the APP/PS1 controls and this correlated, as expected, with the area of amyloid plaques. We conclude that the alterations of intracellular cholesterol present in Npc1 (+/-) mice can influence the progress of Alzheimer's disease in the APP/PS1 mouse model.
虽然尼曼-匹克 C1 病常被称为“少年型阿尔茨海默病”,但将 NPC1 突变引入阿尔茨海默病的小鼠模型中的效果以前尚未进行过研究。我们已经将 NPC1(+/-)小鼠与 APP/PS1“阿尔茨海默病”小鼠杂交,并研究了 Aβ42 积累和淀粉样斑块形成。杂合 NPC1 且 APP 和 PS1 转基因阳性的小鼠比 APP/PS1 对照组更快地积累 Aβ42,这与预期的淀粉样斑块面积相符。我们得出结论,NPC1(+/-)小鼠中存在的细胞内胆固醇的改变可以影响 APP/PS1 小鼠模型中阿尔茨海默病的进展。